Haemonetics Corp. buy Mizuho
Start price
17.12.25
/
50%
€67.50
Target price
17.12.26
€76.62
Performance (%)
-33.04%
Price
12.05.26
€46.00
Summary
This prediction is currently active. The BUY prediction by Mizuho for Haemonetics Corp. is performing very badly with a performance of -33.04%. This prediction currently runs until 17.12.26. The prediction end date can be changed by Mizuho at any time. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Haemonetics Corp. | -3.361% | -3.361% |
| iShares Core DAX® | -1.523% | 0.864% |
| iShares Nasdaq 100 | 3.360% | 15.639% |
| iShares Nikkei 225® | 1.665% | 8.635% |
| iShares S&P 500 | 1.606% | 8.532% |
Comments by Mizuho for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics (NYSE:HAE) had its price target raised by analysts at Mizuho from $75.00 to $90.00. They now have an "outperform" rating on the stock.
Ratings data for HAE provided by MarketBeat
Stopped prediction by Mizuho for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€50.00
13.04.26
13.04.26
€59.89
13.04.27
13.04.27
-10.00%
12.05.26
12.05.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€48.40
06.02.26
06.02.26
€67.86
06.02.27
06.02.27
-4.96%
12.05.26
12.05.26